Health Alert: FDA raised conflict of interest concerns ahead of new panel’s review of controversial peptides
That panel will meet to weigh whether the agency should allow Americans to have broader access to seven injectable peptides previously restricted over potential safety concerns.
That panel will meet to weigh whether the agency should allow Americans to have broader access to seven injectable peptides previously restricted over potential safety concerns.
No comments:
Post a Comment